Madrigal Pharmaceuticals (MDGL) Other Non-Current Assets (2010 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly Other Non-Current Assets came in at $23.5 million in Q1 2026, up 369.96% year-on-year from $5.0 million in Q1 2025, and up 369.96% on a QoQ basis from $5.0 million in Q3 2025.
Madrigal Pharmaceuticals (MDGL) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 9 years of Other Non-Current Assets data on file, last reported at $23.5 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 369.96% year-over-year to $23.5 million in Q1 2026; TTM through Mar 2026 was $23.5 million, a 369.96% increase from a year earlier, with the FY2024 full-year figure at $5.0 million, changed N/A from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $23.5 million, up from $5.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for MDGL reached as high as $23.5 million in Q1 2026 and fell as low as $5.0 million in Q2 2024.
- Historically, Other Non-Current Assets has averaged $7.6 million across 3 years, with a median of $5.0 million in 2024.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2025 and surged 369.96% in 2026, its largest moves.
- Year by year, Other Non-Current Assets stood at $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025, then jumped by 369.96% to $23.5 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $23.5 million in Q1 2026, $5.0 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.50 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Sep 30, 2015 | 226,000.00 |
| Jun 30, 2015 | 278,000.00 |
| Mar 31, 2015 | 564,000.00 |
| Dec 31, 2014 | 305,000.00 |
| Sep 30, 2014 | 331,000.00 |
| Jun 30, 2014 | 358,000.00 |
| Mar 31, 2014 | 384,000.00 |
| Dec 31, 2013 | 1.41 Mn |
| Sep 30, 2013 | 433,000.00 |
| Jun 30, 2013 | 464,000.00 |
| Mar 31, 2013 | 481,000.00 |
| Dec 31, 2012 | 458,000.00 |
| Sep 30, 2012 | 466,000.00 |